Dow Down 0.25% Nasdaq Down 0.14%

Alcobra Ltd. (ADHD)

-NGM
15.91 3.60(18.45%) Sep 29, 4:00PM EDT
Prev Close:19.51
Open:19.14
Bid:16.20 x 1000
Ask:16.51 x 200
1y Target Est:33.63
Beta:1.935
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:15.71 - 19.50
52wk Range:13.63 - 26.96
Volume:868,827
Avg Vol (3m):201,566
Market Cap:217.36M
P/E (ttm):N/A
EPS (ttm):-1.90
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADHD

Comparison

Symbol% ChgMkt Cap
ADHDDown 18.45%217.36M
JNJ300.47B
NVS227.00B
SHPG50.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.18
Quarterly EPS Est (Sep-14) :-0.56
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of proprietary drug candidates. It offers most advanced product (MDX) for the treatment of attention deficit hyperactivity disorder (ADHD) and other cognit... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback